Heart patients get cash and coaching to boost rehab attendance
NCT ID NCT07123480
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether offering heart patients extra support—like a $50 incentive, text messages, case management, and coaching—helps more of them attend cardiac rehabilitation, a program that only 30% of eligible patients currently use. Researchers will also try different ways of asking patients for permission to join the study, to see which approach gets the most people to participate. The goal is to find better strategies to improve heart health in the community.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- monetary incentive, text messages, case management, and physical activity coaching
- What this could lead to
- If successful, this could point to a simple, low-cost way to help more heart patients attend cardiac rehabilitation, which is proven to improve health.
- What could go wrong
- This is a small pilot study, so results may not apply to all hospitals or patients. The extra support may not significantly increase attendance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 160 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Only Baystate Medical Center (Springfield, Massachusetts ) adult patients over age 18 who are admitted to Baystate Medical Center Hospital with a non-surgical qualifying diagnosis for outpatient CR will be included. Common diagnoses include all patients with myocardial infarction, stable angina, percutaneous coronary intervention, transcutaneous aortic/mitral valve replacement, and heart failure. Exclusion Criteria: \- Patients with coronary artery bypass graft surgery, heart valve surgery, or other open-heart surgical procedures will be excluded, as these patients are much more likely attend CR, typically around 70%. In addition, patients who are referred to CR programs outside the region, where enrollment cannot be tracked, will be excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aortic valve replacement are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Every minute counts: study tracks how delays shape heart attack survival
- Can daily mindful breathing ease heart failure symptoms?
- The heart rhythm threat hiding in heart attack wards
- Can a smartphone app keep heart failure patients out of the hospital?
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test